Scientia

Sheriffs Use New Data Analytics to Reduce Crime

Retrieved on: 
Tuesday, January 30, 2024
Intelligence, Scientia, Knowledge, Crime, Domestic violence, CJI, Fair

PLYMOUTH, Mass., Jan. 30, 2024 /PRNewswire/ -- BI² Technologies, a national leader in providing biometric identification technologies, today announced the nation-wide launch of Scientia CJI™, a data analytics system that helps Sheriffs more effectively use actionable intelligence and insight from their existing data to reduce crime in their communities.

Key Points: 
  • PLYMOUTH, Mass., Jan. 30, 2024 /PRNewswire/ -- BI² Technologies, a national leader in providing biometric identification technologies, today announced the nation-wide launch of Scientia CJI™, a data analytics system that helps Sheriffs more effectively use actionable intelligence and insight from their existing data to reduce crime in their communities.
  • Scientia™ CJI Reports, is a data analytics system that helps Sheriffs target resources based on insight from their data.
  • Scientia is a Latin word that means insight and knowledge, based on demonstrable and reproducible data.
  • Scientia CJI™ helps Sheriffs' Offices uncover meaningful patterns, trends, knowledge and – most importantly – provides insights about offenders in their communities from the Criminal Justice Information data the Sheriff's staff collects each day.

Center for Asbestos Related Disease (CARD) Announces New Scientia Publication

Retrieved on: 
Monday, August 14, 2023
CARD, Private sector, Education, Policy, Research, Montana State University, Government, Science, Publication, Asbestos, Autoimmune disease, Medical device, Scientia

LIBBY, Mont., Aug. 14, 2023 /PRNewswire/ -- The Center for Asbestos Related Disease is pleased to announce that Scientia has recently published an article, A Novel Autoimmune Disease Linked to Asbestos Exposure, which looks at the association between the asbestos found in Libby, Montana and autoimmune disease in those environmentally exposed to it.

Key Points: 
  • LIBBY, Mont., Aug. 14, 2023 /PRNewswire/ -- The Center for Asbestos Related Disease is pleased to announce that Scientia has recently published an article, A Novel Autoimmune Disease Linked to Asbestos Exposure, which looks at the association between the asbestos found in Libby, Montana and autoimmune disease in those environmentally exposed to it.
  • "Scientia is a series of research publications covering important issues in science, education and technology, with the sole aim of bridging the gap between science, education, policy, research, government and the private sector.
  • The key aim of Scientia is not to change or challenge the traditional scientific publishing format; instead, we aim to complement this accepted form of dissemination – speaking in a new, easy-to-understand language.
  • The publication is based on the work of frequent CARD collaborator Dr. Jean Pfau, a partially retired microbiologist and immunotoxicologist at Montana State University.

Nutromics attracts world leaders in the emerging field of DNA-based sensing to join its Biosensor Advisory Board

Retrieved on: 
Friday, July 28, 2023
Columbia University, Scientia, University, Thomson Reuters, Johns Hopkins School of Medicine, Believer, Protein folding, University of California, Associate, Biology, Johns Hopkins University, Department of Chemistry, University of Manchester, Johns Hopkins, University of North Carolina at Chapel Hill, La Trobe Institute for Molecular Science, Pharmaceutical industry, Medical imaging, Chemistry, Pharmacology

Nutromics is a leader in continuous DNA-based sensing and is developing the world's first precision diagnostic platform.

Key Points: 
  • Nutromics is a leader in continuous DNA-based sensing and is developing the world's first precision diagnostic platform.
  • The board consists of researchers from Columbia University, University of California, Johns Hopkins, North Carolina State University, and the University of New South Wales.
  • "We've attracted the most acclaimed researchers in the field because we're world leaders in the space of continuous DNA-based sensing," said Nutromics CEO and co-founder Peter Vranes.
  • To achieve this, we need to collaborate with the most experienced experts, and this advisory board represents a major step in that direction."

Sunport Power Brings Its Latest Full Black Flexible PV Module Based On MBC2.0 Technology to SNEC 2023

Retrieved on: 
Friday, June 2, 2023
SNEC, Australian Academy of Science, Human, Scientia, University, MWT, Exhibition, Albuquerque International Sunport, Certification, Sunlight, MBC, CQC, TUV, News, Renewable energy, Science, PV

SHANGHAI, June 2, 2023 /PRNewswire/ -- Sunport Power Corp., Ltd., a leading photovoltaics (PV) MWT technology researcher and PV products manufacturer, has announced the unveiling of its latest solar innovation, the full black PV Modules based on MBC2.0 technology, which debuted at SNEC exhibition in Shanghai, China from 24th May to 26th May.

Key Points: 
  • SHANGHAI, June 2, 2023 /PRNewswire/ -- Sunport Power Corp., Ltd., a leading photovoltaics (PV) MWT technology researcher and PV products manufacturer, has announced the unveiling of its latest solar innovation, the full black PV Modules based on MBC2.0 technology, which debuted at SNEC exhibition in Shanghai, China from 24th May to 26th May.
  • This time, at booth W2-310, Sunport Power showcased the full MWT series products including reinforced flexible modules, full black modules, portable panels and customized flexible modules for various scenarios.
  • "We can see that Sunport Power developed different PV products for different application conditions.
  • "We will bring our new MBC2.0 product and upgraded flexible module product to InterSolar Europe in Munich from 14th to 16th June.

Scientia Raises $50M Growth Equity Investment from Vivo Capital

Retrieved on: 
Thursday, May 27, 2021
Surgery, Medical devices, Finance, Engineering, Professional services, Manufacturing, Health, General Health, Oncology, Vivo, Companies of China, Companies, Surgery, Medical devices, Finance, Engineering, Professional services, Manufacturing, Health, General Health, Oncology, Vivo, Companies of China, Companies, Scientia, Vivo Capital, SCIENTIA, VIVO CAPITAL

Scientia Vascular (Scientia or the Company), a rapidly growing commercial company focused on helping save patients lives with a suite of interventional medical devices, has raised $50M of growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment firm.

Key Points: 
  • Scientia Vascular (Scientia or the Company), a rapidly growing commercial company focused on helping save patients lives with a suite of interventional medical devices, has raised $50M of growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment firm.
  • We look forward to helping Scientia grow in the years ahead, stated Mahendra Shah, Managing Director at Vivo Capital.
  • Vivo looks forward to helping the Company continue to launch new products and expand globally, added Nathan Dau, Executive Director at Vivo Capital.
  • Founded in 1996, Vivo Capital is a leading global healthcare investment firm with a diverse, multi-fund investment platform in venture capital, growth equity, buyout, and public equities.

Scientia Vascular Receives Clearance for the Zoom WireTM and Commences Launch

Retrieved on: 
Thursday, August 6, 2020
FDA, Hospitals, Health, Medical devices, RTT, Stroke, Scientia, FDA, Hospitals, Health, Medical devices, RTT, Stroke, Scientia

Scientia Vascular, a leading innovator in the field of stroke treatment technology, recently received FDA clearance for its Zoom WireTM line of interventional guidewires, which are used to gain access during ischemic and hemorrhagic stroke and other challenging neurovascular and peripheral vascular procedures.

Key Points: 
  • Scientia Vascular, a leading innovator in the field of stroke treatment technology, recently received FDA clearance for its Zoom WireTM line of interventional guidewires, which are used to gain access during ischemic and hemorrhagic stroke and other challenging neurovascular and peripheral vascular procedures.
  • The Zoom Wire incorporates Scientia Vasculars proprietary microfabrication design, enabling a new level of performance for the support and delivery of devices within the brain and other parts of the body.
  • Scientia Vascular Founder and CEO John Lippert stated, We are pleased to offer the Zoom Wire line of guidewire products at a time when clinicians are in need of more supportive guidewires to deliver therapeutic devices quickly in time-critical interventions.
  • Scientia is launching the Zoom Wire products immediately to key customers who have been requesting this follow-on product to the Aristotle 14, 18, and 24 guidewire families.